Inhibitory Effect of KW-3049, a New 1,4-Dihydropyridine Calcium Antagonist, on the Reduction of Myocardial Creatine Kinase Activity and High-Energy Phosphate Content in Rats Subjected to Coronary Artery Ligation.

Journal of Pharmacobio-Dynamics
doi 10.1248/bpb1978.11.722
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmaceutical Society of Japan

Related search

Action of the 1,4-Dihydropyridine Derivative, KW-3049, on the Smooth Muscle Membrane of the Rabbit Mesenteric Artery

British Journal of Pharmacology
Pharmacology
1987English

Hypoglycaemic Brain Damage: Effect of a Dihydropyridine Calcium Channel Antagonist in Rats

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1996English

Protective Effects of Benidipine Hydrochloride (KW-3049), a Calcium Antagonist, Against Experimental Arterial Calcinosis and Endothelial Dysfunction in Rats.

Journal of Pharmacobio-Dynamics
1992English

Metabolism of a New 1,4-Dihydropyridine Calcium Antagonist, Pranidipine, by cDNA-expressed Human Cytochrome P450.

Drug Metabolism and Pharmacokinetics
1998English

Structural Studies of a New Dihydropyridine Calcium Channel Antagonist, Nilvadipine.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1986English

Effect of Milk Fat Content on Absorption of Calcium Carbonate and Calcium Phosphate Mixture in Sprague Dawley Rats

Food Research
Food Science
2019English

Regulation of Sodium-Calcium Exchanger Activity by Creatine Kinase Under Energy-Compromised Conditions

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Creatine Kinase in Periprocedural Myocardial Injury After Percutaneous Coronary Intervention

Vestnik of Saint Petersburg University. Medicine
2017English

Blood Pressure, Resting Energy Expenditure, and Creatine Kinase Activity * Response: Blood Pressure, Resting Energy Expenditure, and Creatine Kinase Activity:

Hypertension
Internal Medicine
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy